About Australian & New Zealand Childhood Hematology & Oncology Group
Clinical Trials at Australian & New Zealand Childhood Hematology & Oncology Group
During the past decade, Australian & New Zealand Childhood Hematology & Oncology Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Australian & New Zealand Childhood Hematology & Oncology Group"
#1 collaborator was "Australian & New Zealand Children's Haematology/Oncology Group" with 2 trials as a collaborator, "Centre Hospitalier Universitaire de Nice" with 2 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "Medical University of Wroclaw (Co-Sponsor Poland)" with 2 trials as a collaborator and "Our Lady's Chilrden's Hospital (Co-Sponsor Ireland)" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Australian & New Zealand Childhood Hematology & Oncology Group
According to Clinical.Site data, the most researched conditions in "Australian & New Zealand Childhood Hematology & Oncology Group" are
"Acute Lymphoblastic Leukemia (ALL)" (2 trials). Many other conditions were trialed in "Australian & New Zealand Childhood Hematology & Oncology Group" in a lesser frequency.
Clinical Trials Intervention Types at Australian & New Zealand Childhood Hematology & Oncology Group
Most popular intervention types in "Australian & New Zealand Childhood Hematology & Oncology Group" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bortezomib" (1 trials), "SR-A + Epratuzumab" (1 trials) and "SR-B + Epratuzumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Australian & New Zealand Childhood Hematology & Oncology Group
The vast majority of trials in "Australian & New Zealand Childhood Hematology & Oncology Group" are
2 trials for "All" genders.
Clinical Trials Status at Australian & New Zealand Childhood Hematology & Oncology Group
Currently, there are NaN active trials in "Australian & New Zealand Childhood Hematology & Oncology Group".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Australian & New Zealand Childhood Hematology & Oncology Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Australian & New Zealand Childhood Hematology & Oncology Group, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".